{{Rsnum
|rsid=17674580
|Gene=SLC14A1
|Chromosome=18
|position=45729946
|Orientation=plus
|GMAF=0.185
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC14A1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 49.2 | 38.5 | 12.3
| HCB | 80.0 | 20.0 | 0.0
| JPT | 80.0 | 20.0 | 0.0
| YRI | 95.2 | 4.8 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 80.0 | 20.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21750109
|Title=European Genome-Wide Association Study Identifies SLC14A1 as a New Urinary Bladder Cancer Susceptibility Gene
|OA=1
}}
{{PMID Auto
|PMID=25218484
|Title=Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians
}}